AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
3.010
+0.010 (0.33%)
At close: Oct 29, 2024, 4:00 PM
3.050
+0.040 (1.33%)
After-hours: Oct 29, 2024, 4:32 PM EDT
AC Immune Market Cap
AC Immune has a market cap or net worth of $297.81 million as of October 29, 2024. Its market cap has increased by 26.62% in one year.
Market Cap
297.81M
Enterprise Value
106.52M
1-Year Change
26.62%
Ranking
Category
Stock Price
$3.01
Market Cap Chart
Since September 23, 2016, AC Immune's market cap has decreased from $867.50M to $297.81M, a decrease of -65.67%. That is a compound annual growth rate of -12.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2024 | 298.60M | -29.51% |
| Dec 29, 2023 | 423.60M | 145.85% |
| Dec 30, 2022 | 172.30M | -52.25% |
| Dec 31, 2021 | 360.80M | -2.88% |
| Dec 31, 2020 | 371.50M | -35.46% |
| Dec 31, 2019 | 575.60M | 6.20% |
| Dec 31, 2018 | 542.00M | -25.42% |
| Dec 29, 2017 | 726.70M | 1.07% |
| Dec 30, 2016 | 719.00M | -17.12% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Design Therapeutics | 313.11M |
| OraSure Technologies | 310.20M |
| Spok Holdings | 306.80M |
| Treace Medical Concepts | 301.00M |
| Inozyme Pharma | 299.87M |
| ADC Therapeutics | 295.86M |
| Delcath Systems | 294.01M |
| Zura Bio | 294.00M |